RecruitingNCT02497521

The German ADPKD Tolvaptan Treatment Registry

The German ADPKD Tolvaptan Treatment Registry is a Prospective, Observational, Multicentric Study of Patients Suffering From ADPKD That Are Considered for Tolvaptan Treatment.

Sponsor

University of Cologne

Enrollment

2,000 participants

Start Date

Nov 1, 2015

Study Type

OBSERVATIONAL

Conditions

ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Summary

The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide "real-world" data on treatment management of patients with ADPKD.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with adpkd (autosomal dominant polycystic kidney disease). The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(12)

Fachinternistische Gemeinschaftspraxis Markgraeferland

Müllheim, Baden-Wurttemberg, Germany

University Hospital of Wuerzburg, ZIM

Würzburg, Bavaria, Germany

Medizinische Hochschule Hannover

Hanover, Lower Saxony, Germany

University Hospital of Cologne

Cologne, North Rhine-Westphalia, Germany

Nieren- und Diabeteszentrum Nettetal-Lobberich

Nettetal, North Rhine-Westphalia, Germany

University Hospital of Leipzig, Nephrologische Ambulanz

Leipzig, Saxony, Germany

Praxisgemeinschaft Dr. Peschel

Leipzig, Saxony, Germany

University Hospital of Schleswig-Holstein

Lübeck, Schleswig-Holstein, Germany

Nierenzentrum Lübeck

Lübeck, Schleswig-Holstein, Germany

Charité Universitätsmedizin Berlin

Berlin, State of Berlin, Germany

University Hospital of Jena

Jena, Thuringia, Germany

Robert-Bosch-Krankenhaus

Stuttgart, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02497521

Related Trials

Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT068006511 location

Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment

NCT066186389 locations